✦ LIBER ✦

Cardiovascular prevention in type 2 diabetes mellitus patients: the role of oral glucose-lowering agents

✍ Scribed by Matteo Anselmino

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Role of Lifestyle and Oral Anti-Diabetic

✍ M. Angelyn Bethel; Robert M. Califf 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 152 KB

Cardiovascular Disease and Oral Agent Gl

✍ Home, Philip 📂 Article 📅 2012 🏛 Mary Ann Liebert 🌐 English ⚖ 836 KB

Drug–Drug Interactions with Sodium-Gluco

✍ Scheen, AndrÃ© J. 📂 Article 📅 2014 🏛 Springer International Publishing AG 🌐 English ⚖ 324 KB

Initiation of glucose-lowering therapy i

✍ J. A. Spoelstra; R. P. Stolk; O. H. Klungel; J. A. Erkens; G. E. H. M. Rutten; H 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 157 KB

Cardiovascular outcome trials of glucose

✍ Yudkin, John S; Vijan, Sandeep; Sussman, Jeremy B; Lehman, Richard; Goldacre, Be 📂 Article 📅 2014 🏛 The Lancet 🌐 English ⚖ 126 KB

Cardiovascular outcome trials of glucose

✍ Vaccaro, Olga; Masulli, Maria; Bonora, Enzo; Del Prato, Stefano; Riccardi, Gabri 📂 Article 📅 2014 🏛 The Lancet 🌐 English ⚖ 74 KB